ID   EPHA7_HUMAN             Reviewed;         998 AA.
AC   Q15375; A0AUX7; B2R8W1; B7ZLJ9; Q59G40; Q5VTU0; Q8N368; Q9H124;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 3.
DT   02-NOV-2010, entry version 119.
DE   RecName: Full=Ephrin type-A receptor 7;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 3;
DE            Short=EHK-3;
DE   AltName: Full=EPH-like kinase 11;
DE            Short=EK11;
DE            Short=hEK11;
DE   Flags: Precursor;
GN   Name=EPHA7; Synonyms=EHK3, HEK11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   MEDLINE=95206782; PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M.,
RA   Basu R., Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT VAL-138.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-791, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-371.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-138; LYS-170; ARG-232; SER-278 AND
RP   SER-903.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds to
CC       ephrin-A1, -A2, -A3, -A4 and -A5.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with PRKCABP and GRIP1 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15375-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15375-2; Sequence=VSP_014382;
CC         Note=May be due to a competing donor splice site;
CC       Name=3;
CC         IsoId=Q15375-3; Sequence=VSP_014380, VSP_014381;
CC         Note=No experimental confirmation available. Ref.6 (AAH27940)
CC         sequence is in conflict in position: 278:R->C;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92506.1; Type=Erroneous initiation;
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EPHA7ID40466ch6q16.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36642; AAA74243.1; -; mRNA.
DR   EMBL; AK313529; BAG36308.1; -; mRNA.
DR   EMBL; AB209269; BAD92506.1; ALT_INIT; mRNA.
DR   EMBL; AL121966; CAC19520.2; -; Genomic_DNA.
DR   EMBL; AL354857; CAH72780.1; -; Genomic_DNA.
DR   EMBL; AL121966; CAH72780.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAH72780.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAH73650.1; -; Genomic_DNA.
DR   EMBL; AL121966; CAH73650.1; JOINED; Genomic_DNA.
DR   EMBL; AL354857; CAH73650.1; JOINED; Genomic_DNA.
DR   EMBL; AL121966; CAI19722.1; -; Genomic_DNA.
DR   EMBL; AL354857; CAI19722.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAI19722.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48518.1; -; Genomic_DNA.
DR   EMBL; BC027940; AAH27940.1; -; mRNA.
DR   EMBL; BC126125; AAI26126.1; -; mRNA.
DR   EMBL; BC126151; AAI26152.1; -; mRNA.
DR   EMBL; BC143857; AAI43858.1; -; mRNA.
DR   IPI; IPI00016645; -.
DR   IPI; IPI00607655; -.
DR   IPI; IPI00607878; -.
DR   PIR; I58351; I58351.
DR   RefSeq; NP_004431.1; -.
DR   UniGene; Hs.73962; -.
DR   PDB; 2REI; X-ray; 1.60 A; A=590-899.
DR   PDB; 3DKO; X-ray; 2.00 A; A=590-899.
DR   PDB; 3H8M; X-ray; 2.10 A; A/B=919-990.
DR   PDBsum; 2REI; -.
DR   PDBsum; 3DKO; -.
DR   PDBsum; 3H8M; -.
DR   ProteinModelPortal; Q15375; -.
DR   SMR; Q15375; 32-205, 327-444, 330-532, 447-539, 905-991.
DR   STRING; Q15375; -.
DR   PhosphoSite; Q15375; -.
DR   PRIDE; Q15375; -.
DR   Ensembl; ENST00000369303; ENSP00000358309; ENSG00000135333.
DR   GeneID; 2045; -.
DR   KEGG; hsa:2045; -.
DR   UCSC; uc003poe.1; human.
DR   UCSC; uc003pof.1; human.
DR   UCSC; uc003pog.2; human.
DR   CTD; 2045; -.
DR   GeneCards; GC06M094007; -.
DR   H-InvDB; HIX0032886; -.
DR   HGNC; HGNC:3390; EPHA7.
DR   HPA; CAB010496; -.
DR   MIM; 602190; gene.
DR   PharmGKB; PA27822; -.
DR   eggNOG; prNOG10836; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; Q15375; -.
DR   OMA; AGYQQKG; -.
DR   OrthoDB; EOG90GG94; -.
DR   PhylomeDB; Q15375; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrina_ephapathway; EphrinA-EPHA pathway.
DR   NextBio; 8311; -.
DR   ArrayExpress; Q15375; -.
DR   Bgee; Q15375; -.
DR   CleanEx; HS_EPHA7; -.
DR   Genevestigator; Q15375; -.
DR   GermOnline; ENSG00000135333; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR009030; Growth_fac_rcpt.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR011510; SAM_2.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020768; Tyr_prot_kinase_EphA_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF278; Tyr_prot_kinase_EphA_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07699; GCC2_GCC3; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF57184; Grow_fac_recept; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     24       Potential.
FT   CHAIN        25    998       Ephrin type-A receptor 7.
FT                                /FTId=PRO_0000016818.
FT   TOPO_DOM     25    556       Extracellular (Potential).
FT   TRANSMEM    557    577       Helical; (Potential).
FT   TOPO_DOM    578    998       Cytoplasmic (Potential).
FT   DOMAIN      331    433       Fibronectin type-III 1.
FT   DOMAIN      443    535       Fibronectin type-III 2.
FT   DOMAIN      633    894       Protein kinase.
FT   DOMAIN      923    987       SAM.
FT   NP_BIND     639    647       ATP (By similarity).
FT   MOTIF       996    998       PDZ-binding (Potential).
FT   COMPBIAS    192    328       Cys-rich.
FT   ACT_SITE    758    758       Proton acceptor (By similarity).
FT   BINDING     665    665       ATP (By similarity).
FT   MOD_RES     608    608       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     614    614       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     791    791       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     940    940       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   CARBOHYD    343    343       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    410    410       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ     278    279       PC -> RK (in isoform 3).
FT                                /FTId=VSP_014380.
FT   VAR_SEQ     280    998       Missing (in isoform 3).
FT                                /FTId=VSP_014381.
FT   VAR_SEQ     540    544       Missing (in isoform 2).
FT                                /FTId=VSP_014382.
FT   VARIANT     138    138       I -> V (in dbSNP:rs2278107).
FT                                /FTId=VAR_022105.
FT   VARIANT     170    170       E -> K (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042150.
FT   VARIANT     232    232       G -> R (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042151.
FT   VARIANT     278    278       P -> S (in dbSNP:rs2278106).
FT                                /FTId=VAR_022106.
FT   VARIANT     371    371       R -> W (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036090.
FT   VARIANT     903    903       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042152.
FT   HELIX       611    613
FT   STRAND      614    616
FT   HELIX       617    624
FT   HELIX       630    632
FT   STRAND      633    638
FT   STRAND      647    649
FT   STRAND      660    666
FT   HELIX       673    685
FT   STRAND      708    712
FT   HELIX       719    725
FT   HELIX       732    735
FT   HELIX       747    751
FT   HELIX       761    763
FT   STRAND      764    766
FT   STRAND      772    774
FT   HELIX       800    802
FT   HELIX       805    810
FT   HELIX       815    821
FT   HELIX       825    830
FT   TURN        836    839
FT   HELIX       842    850
FT   TURN        859    861
FT   HELIX       866    872
FT   HELIX       877    879
FT   HELIX       883    886
FT   HELIX       890    895
FT   HELIX       897    899
SQ   SEQUENCE   998 AA;  112097 MW;  479B9CA0D2BB06EB CRC64;
     MVFQTRYPSW IILCYIWLLR FAHTGEAQAA KEVLLLDSKA QQTELEWISS PPNGWEEISG
     LDENYTPIRT YQVCQVMEPN QNNWLRTNWI SKGNAQRIFV ELKFTLRDCN SLPGVLGTCK
     ETFNLYYYET DYDTGRNIRE NLYVKIDTIA ADESFTQGDL GERKMKLNTE VREIGPLSKK
     GFYLAFQDVG ACIALVSVKV YYKKCWSIIE NLAIFPDTVT GSEFSSLVEV RGTCVSSAEE
     EAENAPRMHC SAEGEWLVPI GKCICKAGYQ QKGDTCEPCG RGFYKSSSQD LQCSRCPTHS
     FSDKEGSSRC ECEDGYYRAP SDPPYVACTR PPSAPQNLIF NINQTTVSLE WSPPADNGGR
     NDVTYRILCK RCSWEQGECV PCGSNIGYMP QQTGLEDNYV TVMDLLAHAN YTFEVEAVNG
     VSDLSRSQRL FAAVSITTGQ AAPSQVSGVM KERVLQRSVE LSWQEPEHPN GVITEYEIKY
     YEKDQRERTY STVKTKSTSA SINNLKPGTV YVFQIRAFTA AGYGNYSPRL DVATLEEATG
     KMFEATAVSS EQNPVIIIAV VAVAGTIILV FMVFGFIIGR RHCGYSKADQ EGDEELYFHF
     KFPGTKTYID PETYEDPNRA VHQFAKELDA SCIKIERVIG AGEFGEVCSG RLKLPGKRDV
     AVAIKTLKVG YTEKQRRDFL CEASIMGQFD HPNVVHLEGV VTRGKPVMIV IEFMENGALD
     AFLRKHDGQF TVIQLVGMLR GIAAGMRYLA DMGYVHRDLA ARNILVNSNL VCKVSDFGLS
     RVIEDDPEAV YTTTGGKIPV RWTAPEAIQY RKFTSASDVW SYGIVMWEVM SYGERPYWDM
     SNQDVIKAIE EGYRLPAPMD CPAGLHQLML DCWQKERAER PKFEQIVGIL DKMIRNPNSL
     KTPLGTCSRP ISPLLDQNTP DFTTFCSVGE WLQAIKMERY KDNFTAAGYN SLESVARMTI
     EDVMSLGITL VGHQKKIMSS IQTMRAQMLH LHGTGIQV
//
